Powerful Medical Receives €40 Million IPCEI Grant — read the full story

Powerful Medical
24. March 2026
3 min to read

Performance of Artificial Intelligence Powered ECG Analysis in Suspected ST-Segment Elevation Myocardial Infarction

Overview

This study evaluates the real-world performance of an AI-based ECG interpretation tool for detecting STEMI in patients undergoing emergent catheterization laboratory activation, using angiographic findings as the reference standard. Compared with standard clinical ECG interpretation, the AI model achieved higher sensitivity and specificity, significantly reducing false-positive activations while maintaining strong performance even in challenging cases such as arrhythmias or conduction abnormalities. These results suggest that AI-assisted ECG analysis can improve diagnostic accuracy, optimize triage, and support faster, more appropriate decision-making in acute coronary syndrome management.

Published in: JACC Advances
Published on: 23 March 2026

Background

Artificial intelligence (AI)–based electrocardiogram (ECG) analysis has emerged as a promising adjunct to human ECG interpretation in suspected ST-segment elevation myocardial infarction (STEMI).

Methods

Consecutive patients were gathered from a multicenter U.S. STEMI registry (2018-2022) and categorized into 3 clinical cohorts based on the presence or absence of angiographic culprit and troponin elevation: acute myocardial infarction (AMI) with culprit, AMI without culprit, and no-AMI. Cardiac catheterization laboratory-activating ECGs were analyzed using an AI-ECG model trained to identify acute coronary occlusion and classified as occlusion myocardial infarction, OMI(+) or not, OMI(−).

Results

The study included 2,523 patients, 68.3% male, with a median age of 63 years. AMI with culprit was present in 2076 (82.3%), AMI without culprit in 314 (12.4%), and no-AMI in 133 (5.3%). Among AMI with culprit patients, the model correctly identified 93.8% as OMI(+). Sensitivity for TIMI flow 0/1, 2, and 3 was 96.3%, 93.1%, and 86.9%, respectively; P < 0.001. The model correctly identified 79.7% of no-AMI patients as OMI(−). The AUCROC was 0.952 (95% CI: 0.924-0.966). The AMI without culprit cohort included takotsubo syndrome OMI(+) = 78%, MI with nonobstructive coronary arteries OMI(+) = 61%, and myopericarditis OMI(+) = 67%.

Conclusion

In suspected STEMI, this AI-ECG model correctly identified nearly all patients with acute coronary obstruction and most of those without AMI. If prospectively validated, this approach could improve the management of patients with suspected AMI.

Performance of Artificial Intelligence Powered ECG Analysis in Suspected ST-Segment Elevation Myocardial Infarction
Authors: Scott W. Sharkey, Robert Herman, Dawn R. Witt, Frank Aguirre, Mehmet Yildiz, David M. Larson, Avinash Murthy, Heather S. Rohm, Stephen W. Smith, Will Belzer, Jenny Chambers, Ellen Cravero, Seth Bergstedt, Greg Kerola, David Farmer, Andrew Willett, H. Pendell Meyers, Julia Harris, Christopher VanHove, and Timothy D. Henry

Author-Logo_PM
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.

About PMcardio

PMcardio is a CE-certified AI that reads ECGs and offers a complex assessment of 49 cardiac conditions. Clinically validated in 15+ studies and trusted by over 100,000 clinicians, it delivers rapid, expert‑level interpretations, empowering emergency physicians, GPs, nurses, paramedics, and cardiologists to act with confidence at the point of care. Available for Individuals and Organizations.

About Powerful Medical

Established in 2017, Powerful Medical has embarked on a mission to revolutionize the diagnosis and treatment of cardiovascular diseases. We are a medical company backed by 28 world-class cardiologists and led by our expert Scientific Board with decades of experience in daily patient care, clinical research, and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.

Share this article

Relevant Publications

Chest Pain With Subtle But Lifesaving ECG Findings

This study presents a clinical case highlighting the diagnostic value of hyperacute T waves on electrocardiogram (ECG) for early detection of acute coronary occlusion. A 54-year-old woman presented with classic ischemic symptoms, yet her initial ECG was interpreted as normal by both automated analysis and clinician review. Closer inspection revealed subtle hyperacute T waves in the anterior leads, consistent with acute occlusion of the left anterior descending (LAD) artery. The case underscores how reliance on traditional ST-segment elevation criteria alone may delay recognition of life-threatening myocardial infarction.

AI-Enhanced Electrocardiogram for Detection of Occlusive Myocardial Infarction in High-Risk Non–ST-Segment Elevation Acute Coronary Syndrome

This study evaluates an AI-enhanced ECG model for detecting occlusive myocardial infarction (OMI) in patients with high-risk non–ST-segment elevation acute coronary syndrome, using angiography as the reference. The model improved rule-in accuracy with high specificity (78%) and reduced false-positive cath lab activations compared with standard care, while rule-out sensitivity remained limited on the initial ECG. Serial ECG analysis improved detection, supporting the use of AI as a triage aid alongside clinical judgment rather than a standalone diagnostic tool.

Join over 100,000 healthcare professionals who are already taking advantage of AI

Discover the future of medical work with us.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.